Cancer Therapy Global Market Report 2025

Description

Cancer therapy refers to treatments aimed at eliminating or controlling cancer cells within the body. It encompasses several methods, including surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy. The selection of treatment depends on the cancer's type, stage, location, and the patient's overall health.

The primary types of cancer therapy include chemotherapy, targeted therapy, immunotherapy, radiotherapy, and others. Chemotherapy involves using potent drugs to kill or inhibit the growth of rapidly dividing cancer cells. It is applied to various cancers such as blood cancer, breast cancer, prostate cancer, gastrointestinal cancer, gynecologic cancer, respiratory or lung cancer, and more. This treatment is utilized by various end users, including hospitals, specialty clinics, and cancer and radiation therapy centers.

The cancer therapy market research report is one of a series of new reports from The Business Research Company that provides cancer therapy market statistics, including the cancer therapy industry global market size, regional shares, competitors with the cancer therapy market share, detailed cancer therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the cancer therapy industry. This cancer therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cancer therapy market size has grown rapidly in recent years. It will grow from $190.44 billion in 2024 to $210.44 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth during the historic period can be attributed to the rising global prevalence of cancer, increasing adoption of chemotherapy treatments, heightened awareness of early cancer diagnosis, greater availability of oncology specialists, and expanded access to hospital-based treatment services.

The cancer therapy market size is expected to see rapid growth in the next few years. It will grow to $310.85 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth projected for the forecast period is driven by increasing demand for personalized cancer therapies, a stronger focus on outpatient cancer care, rising adoption of immunotherapy, improved healthcare access in emerging economies, and a growing incidence of lifestyle-related cancers. Key trends during this period include technological advancements in cancer diagnostics, innovations in targeted drug delivery, increased investment in biologics research and development, the development of AI-based treatment planning, and innovations in minimally invasive cancer surgeries.

The rising prevalence of cancer is expected to drive growth in the cancer therapy market moving forward. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. The increase in cancer cases is mainly due to greater exposure to environmental carcinogens such as pollution and tobacco smoke. Cancer therapy is vital in managing this rising prevalence by treating existing cases, enhancing survival rates, and slowing disease progression. For example, in February 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, projected that global cancer incidence will exceed 35 million new cases by 2050, marking a 77% rise from the estimated 20 million cases reported in 2022. Thus, the growing prevalence of cancer is fueling the expansion of the cancer therapy market.

Leading companies in the cancer therapy market are concentrating on developing innovative treatments, such as immuno-oncology drugs, which enhance treatment effectiveness by leveraging the body's immune system to identify and destroy cancer cells. Immuno-oncology drugs represent a class of cancer therapies that stimulate or boost the immune system's ability to more effectively target and attack cancer cells. For example, in December 2024, Dr. Reddy's Laboratories Ltd., an India-based pharmaceutical firm, launched Toripalimab, the first and only immuno-oncology drug approved for treating nasopharyngeal cancer in India. This introduction offers a new, targeted treatment option for patients with this rare and aggressive cancer, potentially improving outcomes through advanced immune system activation. The availability of Toripalimab in India highlights Dr. Reddy's dedication to increasing access to advanced cancer therapies in underserved regions.

In December 2023, Pfizer Inc., a pharmaceutical company based in the US, acquired Seagen Inc. for $43 billion. Through this acquisition, Pfizer seeks to enhance its oncology portfolio by incorporating Seagen's advanced antibody-drug conjugate (ADC) technology to deliver more targeted cancer treatments. Seagen Inc., also based in the US, specializes in developing ADCs that accurately target cancer cells while reducing damage to healthy tissue.

Major players in the cancer therapy market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, GlaxoSmithKline PLC, Elekta AB, Exelixis Inc., Accuray Incorporated, Akeso Inc., Nanobiotix S.A., SOTIO Biotech a.s., AdvanCell Isotopes Pty Ltd, Axcynsis Therapeutics Pte Ltd, Clarity Pharmaceuticals Ltd, Affimed N.V., and Aptadel Therapeutics S.L.

North America was the largest region in the cancer therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cancer therapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cancer therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cancer therapy market includes revenues earned by entities by providing services such as hormone therapy, stem cell transplant, cryoablation, and photodynamic therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cancer Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cancer therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cancer therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cancer therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Therapy Type: Chemotherapy; Target Therapy; Immunotherapy; Radiotherapy; Other Therapy Types
2) By Cancer Type: Blood Cancer; Breast Cancer; Prostate Cancer; Gastrointestinal Cancer; Gynaecologic Cancer; Respiratory Or Lung Cancer; Other Cancer Types
3) By End User: Hospitals; Specialty Clinics; Cancer And Radiation Therapy Centers
Subsegment:
1) By Chemotherapy: Alkylating Agents; Antimetabolites; Anti-Tumor Antibiotics; Topoisomerase Inhibitors; Mitotic Inhibitors; Corticosteroids; Other Chemotherapy Drugs
2) By Targeted Therapy: Monoclonal Antibodies; Tyrosine Kinase Inhibitors (TKIs); mTOR Inhibitors; Proteasome Inhibitors; PARP Inhibitors; Other Targeted Agents
3) By Immunotherapy: Immune Checkpoint Inhibitors; CAR T-cell Therapy; Cancer Vaccines; Cytokines; Oncolytic Virus Therapy; Other Immunotherapies
4) By Radiotherapy: External Beam Radiation Therapy (EBRT); Internal Radiation Therapy (Brachytherapy); Systemic Radiation Therapy; Stereotactic Radiosurgery (SRS); Intensity-Modulated Radiation Therapy (IMRT); Image-Guided Radiation Therapy (IGRT)
5) By Other Therapy Types: Hormone Therapy; Stem Cell Transplant; Photodynamic Therapy; Cryoablation; Hyperthermia Therapy
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd; Merck & Co. Inc.; Bayer Aktiengesellschaft
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r35860

1. Executive Summary

2. Cancer Therapy Market Characteristics

3. Cancer Therapy Market Trends And Strategies

4. Cancer Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Cancer Therapy Growth Analysis And Strategic Analysis Framework

5.1. Global Cancer Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Cancer Therapy Market Growth Rate Analysis
5.4. Global Cancer Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Cancer Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Cancer Therapy Total Addressable Market (TAM)

6. Cancer Therapy Market Segmentation

6.1. Global Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Chemotherapy
Target Therapy
Immunotherapy
Radiotherapy
Other Therapy Types
6.2. Global Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Blood Cancer
Breast Cancer
Prostate Cancer
Gastrointestinal Cancer
Gynaecologic Cancer
Respiratory Or Lung Cancer
Other Cancer Types
6.3. Global Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Cancer And Radiation Therapy Centers
6.4. Global Cancer Therapy Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Alkylating Agents
Antimetabolites
Anti-Tumor Antibiotics
Topoisomerase Inhibitors
Mitotic Inhibitors
Corticosteroids
Other Chemotherapy Drugs
6.5. Global Cancer Therapy Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monoclonal Antibodies
Tyrosine Kinase Inhibitors (TKIs)
mTOR Inhibitors
Proteasome Inhibitors
PARP Inhibitors
Other Targeted Agents
6.6. Global Cancer Therapy Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immune Checkpoint Inhibitors
CAR T-cell Therapy
Cancer Vaccines
Cytokines
Oncolytic Virus Therapy
Other Immunotherapies
6.7. Global Cancer Therapy Market, Sub-Segmentation Of Radiotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
External Beam Radiation Therapy (EBRT)
Internal Radiation Therapy (Brachytherapy)
Systemic Radiation Therapy
Stereotactic Radiosurgery (SRS)
Intensity-Modulated Radiation Therapy (IMRT)
Image-Guided Radiation Therapy (IGRT)
6.8. Global Cancer Therapy Market, Sub-Segmentation Of Other Therapy Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hormone Therapy
Stem Cell Transplant
Photodynamic Therapy
Cryoablation
Hyperthermia Therapy

7. Cancer Therapy Market Regional And Country Analysis

7.1. Global Cancer Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Cancer Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cancer Therapy Market

8.1. Asia-Pacific Cancer Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cancer Therapy Market

9.1. China Cancer Therapy Market Overview
9.2. China Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cancer Therapy Market

10.1. India Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cancer Therapy Market

11.1. Japan Cancer Therapy Market Overview
11.2. Japan Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cancer Therapy Market

12.1. Australia Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cancer Therapy Market

13.1. Indonesia Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cancer Therapy Market

14.1. South Korea Cancer Therapy Market Overview
14.2. South Korea Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cancer Therapy Market

15.1. Western Europe Cancer Therapy Market Overview
15.2. Western Europe Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cancer Therapy Market

16.1. UK Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cancer Therapy Market

17.1. Germany Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cancer Therapy Market

18.1. France Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cancer Therapy Market

19.1. Italy Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cancer Therapy Market

20.1. Spain Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cancer Therapy Market

21.1. Eastern Europe Cancer Therapy Market Overview
21.2. Eastern Europe Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cancer Therapy Market

22.1. Russia Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cancer Therapy Market

23.1. North America Cancer Therapy Market Overview
23.2. North America Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cancer Therapy Market

24.1. USA Cancer Therapy Market Overview
24.2. USA Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cancer Therapy Market

25.1. Canada Cancer Therapy Market Overview
25.2. Canada Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cancer Therapy Market

26.1. South America Cancer Therapy Market Overview
26.2. South America Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cancer Therapy Market

27.1. Brazil Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cancer Therapy Market

28.1. Middle East Cancer Therapy Market Overview
28.2. Middle East Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cancer Therapy Market

29.1. Africa Cancer Therapy Market Overview
29.2. Africa Cancer Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Cancer Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Cancer Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cancer Therapy Market Competitive Landscape And Company Profiles

30.1. Cancer Therapy Market Competitive Landscape
30.2. Cancer Therapy Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Cancer Therapy Market Other Major And Innovative Companies

31.1. Bristol-Myers Squibb Company
31.2. AstraZeneca PLC
31.3. Novartis International AG
31.4. GlaxoSmithKline PLC
31.5. Elekta AB
31.6. Exelixis Inc.
31.7. Accuray Incorporated
31.8. Akeso Inc.
31.9. Nanobiotix S.A.
31.10. SOTIO Biotech a.s.
31.11. AdvanCell Isotopes Pty Ltd
31.12. Axcynsis Therapeutics Pte Ltd
31.13. Clarity Pharmaceuticals Ltd
31.14. Affimed N.V.
31.15. Aptadel Therapeutics S.L.

32. Global Cancer Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cancer Therapy Market

34. Recent Developments In The Cancer Therapy Market

35. Cancer Therapy Market High Potential Countries, Segments and Strategies

35.1 Cancer Therapy Market In 2029 - Countries Offering Most New Opportunities
35.2 Cancer Therapy Market In 2029 - Segments Offering Most New Opportunities
35.3 Cancer Therapy Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer